Cervical cancer affects women more than any other cancer. A recent study published in The Lancet found that about 1 in every 4 cervical cancers worldwide occurred in India. Thus, by mid-2023, the Indian government will start administering the CERVAVAC vaccine.
Human papillomavirus (HPV) is a sexually transmitted illness that can cause cervical cancer. Cells present in the uterus, the part of the uterus that is closest to the pelvis, are where cervical cancer grows.
Essential Vaccination: Healthcare professionals claim that the vaccine is 99% effective in preventing cervical cancer when given to girls aged 9 to 14 years before sexual contact. In addition, the vaccine can protect against genital warts and cancers of the anus, vulvar, vagina, penile, and oropharynx.
Early signs: If detected early and treated appropriately, cervical cancer is preventable and curable. Early symptoms of cervical cancer include abnormal or irregular bleeding, which occurs between periods or after sexual activity. Additionally, the patient may notice a foul-smelling and/or blood-stained vaginal discharge.
An existing HPV infection cannot be treated. Therefore, immunization may only serve to reduce the risk of HPV infection. Consequently, cervical cancer vaccines should be administered before a woman engages in sexual activity and becomes more likely to be exposed to HPV.
Aftercare: A Pap test is recommended for sexually active women every three years. In a Pap test, the doctor examines the inside of the body and brushes the cervix with a device to collect cells for testing. There is currently no vaccine that can completely protect against the HPV cancer-causing virus.
Right age: Cervical cancer rates can be reduced with Indian vaccines. Doctors recommend two doses in 6 months between 9 and 14 years and two doses for girls between 15 and 26 years, they recommend a three dose regimen. first dose, second dose after one -two months and third dose after six months.